Tech Company Financing Transactions

Seraphina Therapeutics Funding Round

Seraphina Therapeutics, based in San Diego, secured $5 million from Benvolio Group, Domain Associates and Biobrit.

Transaction Overview

Announced On
10/16/2021
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series A
Investors

Benvolio Group (Lead Investor) (Larry Segall)

Domain Associates (Lead Investor)

Biobrit

Cue Ball Group (Mats Lederhausen)

Private Investors (Daniel Bradbury)

Private Investors (Larry Segall)

Private Investors (Lew Frankfort)

Private Investors (Shazi Visram)

Proceeds Purpose
The new funding raised will be used to expand the growth of Seraphina's recurring direct-to-consumer subscription platform as well as developing ingredient opportunities for C15:0 to become an integrated food and beverage fortifier.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2850 Womble Rd. 100-600
San Diego, CA 92106
USA
Phone
Undisclosed
Email Address
Overview
Seraphina Therapeutics is a consortium of scientists, doctors and innovators that uses metabolomics to challenge long held approaches to nutrition, enabling the creation of natural and safe health products designed to support quality of life. We aim to advance products, starting with key fatty acids, that replenish micronutrients and metabolites our bodies already have but need more of as we age.
Profile
Seraphina Therapeutics LinkedIn Company Profile
Social Media
Seraphina Therapeutics Company Twitter Account
Company News
Seraphina Therapeutics News
Facebook
Seraphina Therapeutics on Facebook
YouTube
Seraphina Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chairman
Kim Kamdar
  Kim Kamdar LinkedIn Profile  Kim Kamdar Twitter Account  Kim Kamdar News  Kim Kamdar on Facebook
Chief Executive Officer
Stephanie Venn-Watson
  Stephanie Venn-Watson LinkedIn Profile  Stephanie Venn-Watson Twitter Account  Stephanie Venn-Watson News  Stephanie Venn-Watson on Facebook
Chief Operating Officer
Eric Venn-Watson
  Eric Venn-Watson LinkedIn Profile  Eric Venn-Watson Twitter Account  Eric Venn-Watson News  Eric Venn-Watson on Facebook
Co-Founder
Nicholas Schork
  Nicholas Schork LinkedIn Profile  Nicholas Schork Twitter Account  Nicholas Schork News  Nicholas Schork on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/16/2021: Impartner venture capital transaction
Next: 10/16/2021: Approach venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary